Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
JUBLPHARMA.NS
HoldPremium GrowerJubilant Pharmova Limited · Healthcare · India · $1.7B · Avg Vol: $4M/d
60
StockRankGet insider-trade alerts
Q
50
V
37
M
67
P/E (TTM)
46.0x
ROE
5.6%
D/E
0.5x
Dividend %
0.5%
COMPANY DESCRIPTION
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 62.2B | 66.4B | 71.9B | 82.3B | 9.8% | 86.4B | 93.2B | 106.1B | 13.6% |
| EPS (INR) | -3.83 | 4.87 | 52.99 | 25.15 | 127.3% | 22.23 | 25.71 | 46.24 | 35.6% |
| Shares | 159.1M | 158.4M | 158.4M | 158.4M | -0.4% | 158.4M | — | — | — |
| Debt | 36.8B | 36.6B | 27.3B | 36.1B | -0.6% | 36.3B | — | — | — |
| Equity | 54.0B | 54.3B | 62.5B | 70.9B | 9.5% | — | — | — | — |
| Op CF | 6.6B | 9.7B | 10.7B | 12.3B | 22.9% | 12.3B | — | — | — |
| Inv CF | -5.4B | -6.1B | 4.9B | -12.6B | — | — | — | — | — |
| Fin CF | -1.6B | -4.3B | -14.5B | 949.0M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+6.0%
SMA 50SMA 200
Close
$10.68
RSI (14)
84.9
52W High
$12.35
From 52W High
0.9%
SCORE BREAKDOWN
Quality
50
ROIC
6.3%59.2
ROE
5.6%56.8
GP/Assets
36.0%72.5
Op. Margin
5.4%53.3
FCF/Assets
-1.4%41.7
Piotroski
431.0
Int. Cover
4.0x48.9
D/E Ratio
0.51x28.9
Current Ratio
1.62x29.9
Value
37
P/E (TTM)
46.0x23.6
EV/EBITDA
17.0x41.8
P/FCF
—N/A
P/B
2.3x57.1
P/S
1.9x70.7
Div Yield
0.5%15.6
Momentum
67
52W High %
86%77.8
RS 6M
30%85.3
SMA 50/200
0.98x52.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+128%80.0
Q Growth
-45%11.7
FUNDAMENTALS
Market Cap
$1.7B
P/E (Forward)
20.2x
Gross Margin
65.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of JUBLPHARMA.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| JUBLPHARMA.NS | Jubilant Pharmova Limited(you) | $1.7B | 60 | Hold |
| ERIS.NS | Eris Lifesciences Limited | $1.9B | 56 | Hold |
| SHILPAMED.NS | Shilpa Medicare Limited | $2.0B | 69 | Buy |
| NATCOPHARM.NS | NATCO Pharma Limited | $1.6B | 72 | Buy |
| PPLPHARMA.NS | Piramal Pharma Limited | $3.2B | 58 | Hold |
| NEULANDLAB.NS | Neuland Laboratories Limited | $3.2B | 64 | Hold |
| AARTIPHARM.NS | Aarti Pharmalabs Limited | $829M | 65 | Buy |
| SUDEEPPHRM.NS | Sudeep Pharma Limited | $1.6B | 41 | Hold |
| WOCKPHARMA.NS | Wockhardt Limited | $3.8B | 54 | Hold |
| APLLTD.NS | Alembic Pharmaceuticals Limited | $1.7B | 84 | Strong Buy |
Peer medians: ROE 11.9% · P/E 42.5x · Gross margin 59.4%